怀孕期间使用阿姆洛迪平:阿根廷医疗保健领域的现状
M P Pérez1, A M Ghelfi2, G Miranda3
1Grupo de Trabajo Hipertensión Arterial en la Mujer, Sociedad Argentina de Hipertensión Arterial, Argentina; Servicio de Hipertensión Arterial, Hospital de Agudos J.M. Ramos Mejía, Ciudad Autónoma de Buenos Aires, Argentina.
Hipertension y riesgo vascular
|September 21, 2025
概括
阿姆洛迪平 (AML) 经常被处方用于妊娠高血压疾病 (HDP),63.8%的医生使用它. 缺乏经验和证据是不开出AML的关键原因.
科学领域:
- 产科和妇科 产科和妇科
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 通道阻塞剂 (CCB) 是用于妊娠高血压疾病 (HDP) 的标准.
- 尼菲迪平-RETARD的戒断和配方问题增加了非标签的阿姆洛迪平 (AML) 使用.
- 医生对HDP中AML的处方模式需要调查.
研究的目的:
- 为了确定amlodipine (AML) 在治疗妊娠高血压障碍 (HDP) 的使用频率.
- 描述医生为HDP处方AML的专业特征.
主要方法:
- 在2024年进行的一项描述性,观察性,横截面研究.
- 通过社交媒体和电子邮件向阿根廷治疗HDP的医生分发的封闭数字调查.
- 由阿根廷高血压学会 (SAHA) 开发和验证的调查.
主要成果:
- 调查对276名医生进行了调查,77.1%的医生使用了HDP的CCB,63.8%的医生使用了AML.
- 一般医生 (51%) 是最常见的AML处方者.
- 不给AML处方的常见原因包括缺乏经验 (44.4%) 和认为证据不足 (28.9%).
结论:
- 阿姆洛迪平 (AML) 经常被医生用于妊娠高血压疾病 (HDP).
- 进一步的研究和教育可能会解决AML处方的障碍.
相关概念视频
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:33Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
942
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.5K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.5K